These findings supported the inhibition by VIAN-c4551 of VEGF-mediated endothelial cell permeability in response to melanoma cells and other metastatic cancer cells and encouraged investigating whether this action interfered with the ability of B16-F10 cells to extravasate. The gene discussed is VEGFA; the disease is melanoma.